Results Published From Medtronic’s IN.PACT AV Access Trial
August 19, 2020—Medtronic announced that the primary endpoint results from the IN.PACT AV Access randomized controlled trial of the company's In.Pact AV drug-coated balloon (DCB) were published by Robert A. Lookstein, MD, et al in The New England Journal of Medicine (2020;383:733-742). The company noted that the In.Pact AV DCB, which is approved for the treatment of failing arteriovenous (AV) access, met both its primary safety and effectiveness endpoints.
